The Dual Role of Mesenchymal Stem Cells in Cancer Pathophysiology: Pro-Tumorigenic Effects versus Therapeutic Potential.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
31 Aug 2023
Historique:
received: 02 08 2023
revised: 29 08 2023
accepted: 30 08 2023
medline: 11 9 2023
pubmed: 9 9 2023
entrez: 9 9 2023
Statut: epublish

Résumé

Mesenchymal stem/stromal cells (MSCs) are multipotent cells involved in numerous physiological events, including organogenesis, the maintenance of tissue homeostasis, regeneration, or tissue repair. MSCs are increasingly recognized as playing a major, dual, and complex role in cancer pathophysiology through their ability to limit or promote tumor progression. Indeed, these cells are known to interact with the tumor microenvironment, modulate the behavior of tumor cells, influence their functions, and promote distant metastasis formation through the secretion of mediators, the regulation of cell-cell interactions, and the modulation of the immune response. This dynamic network can lead to the establishment of immunoprivileged tissue niches or the formation of new tumors through the proliferation/differentiation of MSCs into cancer-associated fibroblasts as well as cancer stem cells. However, MSCs exhibit also therapeutic effects including anti-tumor, anti-proliferative, anti-inflammatory, or anti-oxidative effects. The therapeutic interest in MSCs is currently growing, mainly due to their ability to selectively migrate and penetrate tumor sites, which would make them relevant as vectors for advanced therapies. Therefore, this review aims to provide an overview of the double-edged sword implications of MSCs in tumor processes. The therapeutic potential of MSCs will be reviewed in melanoma and lung cancers.

Identifiants

pubmed: 37686315
pii: ijms241713511
doi: 10.3390/ijms241713511
pmc: PMC10488262
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Nature. 2018 Feb 22;554(7693):544-548
pubmed: 29443960
Int J Mol Sci. 2021 Sep 10;22(18):
pubmed: 34575965
Immunology. 2018 Nov;155(3):346-355
pubmed: 29923617
Breast Cancer Res Treat. 2007 Oct;105(2):157-67
pubmed: 17221158
Stem Cell Res Ther. 2013 Jun 13;4(3):70
pubmed: 23763837
Nature. 2018 Feb 22;554(7693):475-480
pubmed: 29443965
J Nanobiotechnology. 2020 Sep 3;18(1):122
pubmed: 32883290
Cell Stem Cell. 2008 Feb 7;2(2):141-50
pubmed: 18371435
Oncotarget. 2017 Aug 14;8(42):73296-73311
pubmed: 29069870
Breast Cancer. 2021 Jul;28(4):904-914
pubmed: 33629216
Circulation. 1994 Aug;90(2):649-52
pubmed: 8044933
Nature. 2020 Nov;587(7835):619-625
pubmed: 33208946
Nat Biotechnol. 2012 Jul 10;30(7):658-70
pubmed: 22781695
Sci Rep. 2018 May 16;8(1):7716
pubmed: 29769543
Oncotarget. 2019 Jan 29;10(9):993-1009
pubmed: 30847027
Cell. 2008 May 16;133(4):704-15
pubmed: 18485877
PLoS One. 2015 Feb 23;10(2):e0118058
pubmed: 25706718
Oncotarget. 2016 Nov 8;7(45):73032-73044
pubmed: 27682876
Stem Cells Int. 2018 Apr 5;2018:3524759
pubmed: 30026761
Theranostics. 2019 Jan 1;9(2):436-448
pubmed: 30809285
Open Biol. 2012 May;2(5):120066
pubmed: 22724067
Stem Cells. 2014 Jun;32(6):1408-19
pubmed: 24578244
Drug Des Devel Ther. 2014 Dec 09;8:2449-62
pubmed: 25525335
J Clin Invest. 2011 Aug;121(8):3206-19
pubmed: 21737876
Nat Rev Neurosci. 2022 Jan;23(1):23-34
pubmed: 34671105
Nature. 2022 Mar;603(7903):893-899
pubmed: 35158371
Cell. 2010 Oct 29;143(3):355-66
pubmed: 21029859
Nat Neurosci. 2021 Feb;24(2):234-244
pubmed: 33526922
Gene Ther. 2011 May;18(5):488-95
pubmed: 21228885
Gene Ther. 2009 Feb;16(2):262-78
pubmed: 19078993
Cancer Res. 2009 May 15;69(10):4134-42
pubmed: 19435900
Biochim Biophys Acta. 2016 Dec;1866(2):290-299
pubmed: 27750042
Biotechnol Appl Biochem. 2004 Aug;40(Pt 1):17-24
pubmed: 15270703
Cell Mol Life Sci. 2006 Jul;63(14):1649-57
pubmed: 16786223
J Exp Med. 2006 May 15;203(5):1235-47
pubmed: 16636132
Sci Transl Med. 2022 Feb 2;14(630):eabf5473
pubmed: 35108062
J Vasc Res. 1999 Jan-Feb;36(1):2-27
pubmed: 10050070
PLoS Genet. 2020 Oct 26;16(10):e1008800
pubmed: 33104690
Stem Cells Dev. 2016 Sep 7;25(20):1513-1531
pubmed: 27460260
Cell Physiol Biochem. 2014;33(6):1802-14
pubmed: 24923759
Front Immunol. 2021 Sep 06;12:735133
pubmed: 34552594
Cytokine Growth Factor Rev. 2020 Dec;56:28-38
pubmed: 32660751
Cancer Cell. 2014 Jan 13;25(1):37-48
pubmed: 24434209
Cell Biosci. 2021 Jun 10;11(1):109
pubmed: 34112253
Nat Med. 1998 May;4(5):627-30
pubmed: 9585241
J Pathol. 2011 Jan;223(2):205-18
pubmed: 20957627
Int J Mol Sci. 2022 Mar 02;23(5):
pubmed: 35269887
Carcinogenesis. 2016 Oct;37(10):972-984
pubmed: 27520561
Front Immunol. 2020 Aug 14;11:1843
pubmed: 32922398
J Cell Mol Med. 2011 Nov;15(11):2343-52
pubmed: 21091630
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Drug Resist Updat. 2015 Mar;19:33-42
pubmed: 25575621
Cancer Cell. 2011 Sep 13;20(3):370-83
pubmed: 21907927
J Gene Med. 2015 Jan-Feb;17(1-2):54-67
pubmed: 25677845
Exp Mol Pathol. 2003 Dec;75(3):248-55
pubmed: 14611816
Cytotherapy. 2005;7(5):393-5
pubmed: 16236628
Genes Dev. 2013 Oct 15;27(20):2192-206
pubmed: 24142872
J Exp Clin Cancer Res. 2022 Nov 3;41(1):319
pubmed: 36324182
Cell. 2018 Aug 9;174(4):1015-1030.e16
pubmed: 30096299
Cell Death Discov. 2017 Feb 06;3:17002
pubmed: 28180000
Cancer Discov. 2012 Sep;2(9):840-55
pubmed: 22763855
Curr Cancer Drug Targets. 2018;18(2):171-176
pubmed: 29189159
Int J Cancer. 2008 Nov 15;123(10):2229-38
pubmed: 18777559
J Control Release. 2015 Jul 10;209:260-71
pubmed: 25966361
Nat Rev Cancer. 2017 Aug;17(8):457-474
pubmed: 28706266
J Natl Cancer Inst. 2006 Dec 20;98(24):1777-85
pubmed: 17179479
Cancer Res. 2011 Jul 1;71(13):4653-63
pubmed: 21518779
PLoS One. 2012;7(4):e35036
pubmed: 22496888
Development. 2004 Oct;131(19):4637-50
pubmed: 15358668
J Biol Chem. 2003 Jun 6;278(23):21113-23
pubmed: 12665527
Oncotarget. 2016 Apr 12;7(15):20934-44
pubmed: 26988913
J Hematol Oncol. 2014 Feb 06;7:14
pubmed: 24502410
Methods Mol Biol. 2013;946:335-47
pubmed: 23179842
Cytotherapy. 2013 Feb;15(2):140-5
pubmed: 23321325
Adv Wound Care (New Rochelle). 2012 Aug;1(4):147-152
pubmed: 24527296
Hum Gene Ther. 2007 Jul;18(7):627-41
pubmed: 17604566
Nat Rev Clin Oncol. 2017 Oct;14(10):611-629
pubmed: 28397828
Srp Arh Celok Lek. 2013 Mar-Apr;141(3-4):178-86
pubmed: 23745340
Tissue Eng. 2001 Apr;7(2):211-28
pubmed: 11304456
Br J Cancer. 2008 Aug 19;99(4):622-31
pubmed: 18665180
CA Cancer J Clin. 2022 Jan;72(1):7-33
pubmed: 35020204
Cell Mol Biol Lett. 2021 Jan 20;26(1):3
pubmed: 33472580
Expert Opin Biol Ther. 2010 Apr;10(4):505-17
pubmed: 20218920
Cancers (Basel). 2020 Jul 29;12(8):
pubmed: 32751163
Anticancer Res. 2020 Jun;40(6):3039-3047
pubmed: 32487597
Tissue Eng Regen Med. 2022 Oct;19(5):1013-1031
pubmed: 35511336
J Embryol Exp Morphol. 1966 Dec;16(3):381-90
pubmed: 5336210
Int J Cancer. 2016 Dec 15;139(12):2802-2811
pubmed: 27558972
J Control Release. 2013 Aug 10;169(3):257-65
pubmed: 23562633
Stem Cells Int. 2021 Jun 29;2021:9989790
pubmed: 34306099
Stem Cells Dev. 2015 May 15;24(10):1205-22
pubmed: 25525832
Adv Healthc Mater. 2022 Apr;11(8):e2200143
pubmed: 35195958
Acta Haematol. 2016;136(2):85-97
pubmed: 27188909
Stem Cells. 2010 Aug;28(8):1446-55
pubmed: 20597105
Nat Rev Cancer. 2006 May;6(5):392-401
pubmed: 16572188
Cancer Gene Ther. 2011 Apr;18(4):229-39
pubmed: 21037557
Mol Cancer. 2015 Jan 27;14:14
pubmed: 25623255
J Invest Dermatol. 2009 Nov;129(11):2686-93
pubmed: 19516266
Nat Rev Immunol. 2018 Nov;18(11):689-702
pubmed: 30127389
Int J Mol Sci. 2022 Jul 21;23(14):
pubmed: 35887383
J Cancer. 2017 Feb 25;8(5):761-773
pubmed: 28382138
J Natl Cancer Inst. 2004 Nov 3;96(21):1593-603
pubmed: 15523088
Expert Opin Ther Targets. 2010 Jul;14(7):681-92
pubmed: 20446866
Nat Cell Biol. 2015 Feb;17(2):170-82
pubmed: 25580734
Mol Ther. 2016 Feb;24(1):6-16
pubmed: 26478249
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Stem Cells. 2009 Jun;27(6):1366-75
pubmed: 19489099
Stem Cells. 2007 Nov;25(11):2739-49
pubmed: 17656645
Leukemia. 2007 Feb;21(2):304-10
pubmed: 17170725
Stem Cell Res Ther. 2016 Nov 10;7(1):163
pubmed: 27832825
Front Cell Dev Biol. 2020 Oct 30;8:587776
pubmed: 33195245
J Hematol Oncol. 2021 Nov 17;14(1):195
pubmed: 34789315
Mol Biol Cell. 2003 May;14(5):1790-800
pubmed: 12802055
Biologicals. 2020 Nov;68:9-18
pubmed: 33032882
Radiother Oncol. 2013 Sep;108(3):378-87
pubmed: 23830195
Clin Cancer Res. 2009 Dec 1;15(23):7246-55
pubmed: 19934299
Cell Commun Signal. 2023 Feb 24;21(1):43
pubmed: 36829187
J Bone Miner Res. 1997 Sep;12(9):1335-47
pubmed: 9286749
Oral Oncol. 2015 Dec;51(12):1095-102
pubmed: 26454580
Signal Transduct Target Ther. 2022 Apr 8;7(1):100
pubmed: 35393389
Cancer Res. 2008 Jun 1;68(11):4331-9
pubmed: 18519693
Cell Rep. 2020 May 19;31(7):107628
pubmed: 32433953
Int J Cancer. 2011 Feb 1;128(3):715-25
pubmed: 20725999
Int J Oncol. 2012 Jan;40(1):130-8
pubmed: 21904773
J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S78-86
pubmed: 22018071
Immunobiology. 2016 Feb;221(2):129-36
pubmed: 26416211
Cell. 2006 Jan 27;124(2):263-6
pubmed: 16439202
Pharmaceutics. 2021 Jun 21;13(6):
pubmed: 34205513
Stem Cells Int. 2017;2017:6294717
pubmed: 28798777
J Vis Exp. 2017 Apr 3;(122):
pubmed: 28447991
EBioMedicine. 2018 Mar;29:128-145
pubmed: 29503225
Biomolecules. 2020 Apr 21;10(4):
pubmed: 32326356
Stem Cells. 2007 Jul;25(7):1737-45
pubmed: 17395768
Mol Ther. 2010 Jan;18(1):223-31
pubmed: 19844197
J Cell Biochem. 2015 Apr;116(4):618-27
pubmed: 25399738
Biochim Biophys Acta. 2014 Aug;1840(8):2506-19
pubmed: 24418517
Ann Thorac Surg. 2009 Sep;88(3):1036-43
pubmed: 19699961
Nat Rev Cancer. 2019 Apr;19(4):215-227
pubmed: 30867580
World J Stem Cells. 2016 Mar 26;8(3):73-87
pubmed: 27022438
Open Biol J. 2010 Jan 1;3:8-14
pubmed: 20882121
ACS Appl Mater Interfaces. 2021 Jun 23;13(24):28650-28661
pubmed: 34124895
J Control Release. 2019 Jan 28;294:102-113
pubmed: 30553849
Sci Rep. 2015 Nov 20;5:16941
pubmed: 26585689
Curr Med Chem. 2016;23(5):455-63
pubmed: 26674785
Bull Exp Biol Med. 2020 Feb;168(4):561-565
pubmed: 32152845
PLoS One. 2020 Oct 29;15(10):e0241423
pubmed: 33119681
Cell Stem Cell. 2012 Jun 14;10(6):709-716
pubmed: 22704511
Int J Nanomedicine. 2020 Nov 24;15:9407-9430
pubmed: 33262595
J Clin Invest. 2013 Jan;123(1):189-205
pubmed: 23318994
Int Immunopharmacol. 2022 Jul;108:108882
pubmed: 35623296
Oncogene. 2017 Nov 2;36(44):6097-6108
pubmed: 28671670
Blood. 2000 Oct 15;96(8):2655-63
pubmed: 11023495
J Exp Clin Cancer Res. 2019 May 8;38(1):186
pubmed: 31068208
Cell Rep. 2017 Jan 31;18(5):1215-1228
pubmed: 28147276
Front Cell Dev Biol. 2020 Jun 19;8:447
pubmed: 32637408
PLoS One. 2014 Feb 06;9(2):e87893
pubmed: 24516569
Stem Cells. 2008 Sep;26(9):2332-8
pubmed: 18617688
Cancer Res. 2005 Apr 15;65(8):3307-18
pubmed: 15833864
Cell Transplant. 2011;20(5):681-91
pubmed: 21054933
Stem Cells. 2019 Feb;37(2):257-269
pubmed: 30353617
Curr Probl Cancer. 2021 Feb;45(1):100639
pubmed: 32828575
Cell Adh Migr. 2013 May-Jun;7(3):315-24
pubmed: 23722213
Exp Mol Med. 2010 Apr 30;42(4):280-93
pubmed: 20177148
Ann Oncol. 2012 Mar;23(3):597-604
pubmed: 21551002
Nano Today. 2019 Apr;25:85-98
pubmed: 31360214
J Hematol Oncol. 2019 Sep 10;12(1):95
pubmed: 31500658
Cancer Lett. 2008 Sep 28;269(1):67-77
pubmed: 18571836
Nat Rev Cancer. 2005 Dec;5(12):965-76
pubmed: 16294217
J Gene Med. 2008 Oct;10(10):1071-82
pubmed: 18671316
J Orthop Res. 1991 Sep;9(5):641-50
pubmed: 1870029
Cancer Res. 2013 Jan 1;73(1):364-72
pubmed: 23066037
Cell. 2007 Jun 29;129(7):1377-88
pubmed: 17604725
Front Immunol. 2021 Mar 16;12:623973
pubmed: 33796099
J Oral Pathol Med. 2022 Aug;51(7):638-648
pubmed: 35792829
Cancer Res. 2013 Oct 15;73(20):6185-93
pubmed: 23966294
J Clin Invest. 2016 May 2;126(5):1834-56
pubmed: 27043285
EBioMedicine. 2019 Jul;45:39-57
pubmed: 31281099
Dev Cell. 2011 Aug 16;21(2):193-215
pubmed: 21839917
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
pubmed: 24556840
Carcinogenesis. 2011 Apr;32(4):477-87
pubmed: 21252118
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Anticancer Res. 2015 Jan;35(1):159-68
pubmed: 25550547
Eur J Immunol. 2010 Nov;40(11):2969-75
pubmed: 21061430
Cancer Res. 2002 Jul 1;62(13):3603-8
pubmed: 12097260
Mol Biol Cell. 2002 Dec;13(12):4279-95
pubmed: 12475952
Curr Med Res Opin. 2015 May;31(5):987-91
pubmed: 25708472
Stem Cells Transl Med. 2015 Apr;4(4):359-68
pubmed: 25742693
Cell Stem Cell. 2008 Sep 11;3(3):301-13
pubmed: 18786417
Stem Cells Int. 2019 Nov 12;2019:9618065
pubmed: 31781251
Mol Cancer. 2017 Feb 1;16(1):28
pubmed: 28148265
Cancer Lett. 2021 Apr 10;503:19-31
pubmed: 33472090
Cancer Lett. 2018 Aug 1;428:34-44
pubmed: 29702191
Br J Cancer. 2012 Jun 5;106(12):1901-6
pubmed: 22596239
Front Immunol. 2019 Aug 02;10:1835
pubmed: 31428105
Cancer Sci. 2013 Feb;104(2):157-64
pubmed: 23121112
Clin Cancer Res. 2007 Sep 1;13(17):5020-7
pubmed: 17785552
Cancer Biother Radiopharm. 2021 May;36(4):305-306
pubmed: 32996779
Int J Mol Sci. 2021 Nov 18;22(22):
pubmed: 34830312
Int J Nanomedicine. 2019 Dec 02;14:9483-9496
pubmed: 31819445
Cancer Lett. 2016 Dec 1;383(1):18-27
pubmed: 27693460
Future Virol. 2017 Apr;12(4):193-213
pubmed: 29387140
Sci Rep. 2021 Feb 25;11(1):4690
pubmed: 33633222
Mol Med. 2011;17(7-8):579-87
pubmed: 21424106
Nat Commun. 2021 Feb 1;12(1):723
pubmed: 33526787
Methods Cell Biol. 2004;75:559-76
pubmed: 15603442
Nanomedicine. 2015 Apr;11(3):657-70
pubmed: 25645959
Nat Rev Cancer. 2020 Mar;20(3):174-186
pubmed: 31980749
Mol Cancer. 2017 Jan 30;16(1):10
pubmed: 28137309
Int J Mol Sci. 2015 Dec 16;16(12):30015-33
pubmed: 26694366
Stem Cells Transl Med. 2017 Dec;6(12):2115-2125
pubmed: 29072369
Stem Cells. 2007 Sep;25(9):2363-70
pubmed: 17540857
Cell Mol Life Sci. 2020 Jul;77(14):2771-2794
pubmed: 31965214
Cancer Lett. 2010 Apr 28;290(2):157-66
pubmed: 19786319
Cancers (Basel). 2021 Jan 06;13(2):
pubmed: 33418929
Cancer Res. 2007 Jul 1;67(13):6304-13
pubmed: 17616689
Arthritis Rheum. 2001 Aug;44(8):1928-42
pubmed: 11508446
Front Cell Dev Biol. 2020 Aug 13;8:788
pubmed: 32903528
Mol Cell Biochem. 2013 Nov;383(1-2):13-20
pubmed: 23812844
Int J Cancer. 1989 Mar 15;43(3):526-30
pubmed: 2494120
Oncol Lett. 2016 Feb;11(2):1089-1094
pubmed: 26893697
Hum Cell. 2021 Nov;34(6):1812-1829
pubmed: 34431063
Cancer Cell. 2009 Jan 6;15(1):21-34
pubmed: 19111878
J Immunol. 2015 Apr 1;194(7):3463-74
pubmed: 25712213
Neurosurg Rev. 2021 Feb;44(1):29-49
pubmed: 31781985
Acta Neuropathol Commun. 2023 Jun 24;11(1):104
pubmed: 37355636
Int J Oncol. 2020 Sep;57(3):619-630
pubmed: 32705148
Sci Rep. 2016 Feb 19;6:21420
pubmed: 26892992
Stem Cell Res Ther. 2022 Mar 7;13(1):97
pubmed: 35255980
Nature. 2020 Dec;588(7838):466-472
pubmed: 32971526
J Clin Invest. 2009 Dec;119(12):3613-25
pubmed: 19920354
PLoS One. 2012;7(12):e50946
pubmed: 23284651
Mol Cell Probes. 1987 Dec;1(4):297-326
pubmed: 3330997
Hum Gene Ther. 2014 Apr;25(4):265-84
pubmed: 24512150
Front Oncol. 2020 Sep 09;10:1786
pubmed: 33014876
J Vis Exp. 2016 Jun 06;(112):
pubmed: 27340821
Breast Cancer Res Treat. 2015 Apr;150(2):255-63
pubmed: 25721605
Cell Stem Cell. 2012 Dec 7;11(6):812-24
pubmed: 23168163
Nat Rev Cancer. 2016 Aug 23;16(9):582-98
pubmed: 27550820
Drug Deliv. 2017 Nov;24(1):1372-1383
pubmed: 28920712
Leukemia. 2002 Sep;16(9):1713-24
pubmed: 12200686
World J Stem Cells. 2012 Jun 26;4(6):53-61
pubmed: 22993662
Blood. 2005 Feb 1;105(3):1094-101
pubmed: 15459006
Clin Orthop Relat Res. 1991 Jan;(262):298-311
pubmed: 1984928
Stem Cell Res Ther. 2016 Oct 10;7(1):149
pubmed: 27724977
PLoS One. 2013 Sep 09;8(9):e74897
pubmed: 24040358
PLoS One. 2012;7(9):e45590
pubmed: 23029122
Breast Cancer Res Treat. 2010 Nov;124(2):317-26
pubmed: 20087650
Nat Rev Cancer. 2012 Mar 15;12(4):298-306
pubmed: 22419253
Cancer Lett. 2023 Mar 1;556:216074
pubmed: 36682706
Prostate. 2019 Feb;79(3):320-330
pubmed: 30488530
Methods Mol Biol. 2012;797:97-109
pubmed: 21948472
Theranostics. 2019 Apr 13;9(8):2411-2423
pubmed: 31149052
Stem Cells. 2010 Nov;28(11):2109-20
pubmed: 20882532
Nat Rev Cancer. 2009 Sep;9(9):665-74
pubmed: 19693095
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12493-8
pubmed: 16891410
Cancers (Basel). 2023 May 07;15(9):
pubmed: 37174113
Cell Tissue Kinet. 1970 Oct;3(4):393-403
pubmed: 5523063
Neuro Oncol. 2005 Oct;7(4):452-64
pubmed: 16212810
Hum Vaccin Immunother. 2020 Oct 2;16(10):2389-2402
pubmed: 32078405
Neuroimmunomodulation. 2013;20(5):294-303
pubmed: 23899693
Nat Commun. 2022 Jun 14;13(1):3409
pubmed: 35701396
Stem Cells. 2022 Aug 25;40(8):705-715
pubmed: 35583414
Mol Cancer. 2017 Feb 1;16(1):31
pubmed: 28148268
J Neuropathol Exp Neurol. 2004 Dec;63(12):1274-83
pubmed: 15624764
PLoS One. 2009;4(4):e4992
pubmed: 19352430
Cell Stem Cell. 2008 Apr 10;2(4):313-9
pubmed: 18397751
Exp Cell Res. 2010 Sep 10;316(15):2513-26
pubmed: 20430024
Int J Clin Exp Pathol. 2022 Oct 15;15(10):403-411
pubmed: 36381422
Heliyon. 2023 Feb 10;9(2):e13464
pubmed: 36865479
BMC Med. 2008 Apr 28;6:11
pubmed: 18442412
Cancer Lett. 2021 Jul 1;509:26-38
pubmed: 33819529
Cancer Gene Ther. 2012 Sep;19(9):652-8
pubmed: 22767216
Respiration. 2013;85(6):443-51
pubmed: 23711430
Int J Oncol. 2015 Jul;47(1):244-52
pubmed: 25963929
Stem Cells. 2008 Sep;26(9):2287-99
pubmed: 18566331
Oncotarget. 2015 Apr 10;6(10):8323-38
pubmed: 25831050
Cancer Biol Ther. 2008 Feb;7(2):245-51
pubmed: 18059192
Front Physiol. 2015 Dec 02;6:367
pubmed: 26696901
Adv Exp Med Biol. 2020;1234:31-42
pubmed: 32040853
J Cell Physiol. 2018 Jan;233(1):201-213
pubmed: 28213973
Expert Opin Biol Ther. 2010 Mar;10(3):353-68
pubmed: 20132057
J Pathol. 2020 Apr;250(5):555-572
pubmed: 31608444
Cell Commun Signal. 2016 Sep 08;14(1):20
pubmed: 27608835
Cancer Cell Int. 2021 Nov 4;21(1):595
pubmed: 34736460
Oncotarget. 2018 May 15;9(37):24766-24777
pubmed: 29872504
Cell Commun Signal. 2016 Jan 12;14:4
pubmed: 26759169
Cancers (Basel). 2021 Dec 07;13(24):
pubmed: 34944793
Radiat Oncol. 2015 Aug 06;10:164
pubmed: 26245666
Cell Stem Cell. 2014 Mar 6;14(3):275-91
pubmed: 24607403
Cancer Immunol Res. 2015 Jan;3(1):1-11
pubmed: 25568067
Int J Stem Cells. 2017 Nov 30;10(2):184-192
pubmed: 28844128
Blood. 2002 Mar 15;99(6):2179-84
pubmed: 11877295
Mol Ther. 2016 Feb;24(1):175-83
pubmed: 26310629
Stem Cell Res Ther. 2016 May 12;7(1):71
pubmed: 27176654
Int J Cancer. 2016 Jan 15;138(2):417-27
pubmed: 26235173
PLoS One. 2010 Apr 26;5(4):e10088
pubmed: 20436665
Curr Cancer Drug Targets. 2018;18(2):177-187
pubmed: 28228086
Oncotarget. 2016 Feb 9;7(6):6916-32
pubmed: 26755648
Oncogene. 2013 Sep 12;32(37):4343-54
pubmed: 23085755
Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):618-23
pubmed: 17202265
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2397-402
pubmed: 12606728
Stem Cells. 2006 Jul;24(7):1750-8
pubmed: 16822883
Oncotarget. 2016 Sep 13;7(37):60752-60774
pubmed: 27542276
Clin Cancer Res. 2005 Aug 15;11(16):5965-70
pubmed: 16115940
J Invest Dermatol. 2005 Jan;124(1):28-37
pubmed: 15654950
Nat Neurosci. 2019 Jun;22(6):1021-1035
pubmed: 31061494
Cancer Cell. 2011 Feb 15;19(2):257-72
pubmed: 21316604
Science. 2011 Mar 25;331(6024):1559-64
pubmed: 21436443
Semin Cancer Biol. 2017 Dec;47:185-195
pubmed: 28782608
Lab Invest. 2005 Aug;85(8):962-71
pubmed: 15924148
PLoS One. 2008;3(12):e3894
pubmed: 19079610
J Cell Sci. 2006 Jun 1;119(Pt 11):2204-13
pubmed: 16684817
Cell. 2016 Jun 30;166(1):21-45
pubmed: 27368099
Sci Adv. 2022 Jun 10;8(23):eabm6340
pubmed: 35675414
Vaccines (Basel). 2016 Nov 08;4(4):
pubmed: 27834810
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4504-12
pubmed: 25288727
Cell Commun Signal. 2018 Jan 5;16(1):2
pubmed: 29329589
J Cell Biochem. 2006 Aug 1;98(5):1076-84
pubmed: 16619257
Stem Cells. 2016 Oct;34(10):2536-2547
pubmed: 27300750
Stem Cell Investig. 2015 Mar 26;2:6
pubmed: 27358874
J Surg Res. 2003 Apr;110(2):383-92
pubmed: 12788669
Science. 2011 Jul 8;333(6039):238-42
pubmed: 21737741
Oncotarget. 2016 Jul 26;7(30):48296-48308
pubmed: 27340780
Stem Cells. 2015 Nov;33(11):3281-90
pubmed: 26086742
Gene Ther. 2008 Nov;15(21):1446-53
pubmed: 18596829
J Cell Sci. 2012 Dec 1;125(Pt 23):5591-6
pubmed: 23420197
Nat Rev Immunol. 2008 Sep;8(9):726-36
pubmed: 19172693
Cancer Res. 2009 Dec 1;69(23):8862-7
pubmed: 19920196
N Engl J Med. 2016 Sep 1;375(9):819-29
pubmed: 27433843
Front Cell Dev Biol. 2021 Jun 11;9:676342
pubmed: 34179005
Circ Res. 2011 Sep 30;109(8):923-40
pubmed: 21960725
Nat Rev Drug Discov. 2015 Sep;14(9):642-62
pubmed: 26323545
Nanomedicine. 2014 Jan;10(1):257-67
pubmed: 23770065
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7841-5
pubmed: 11427725
Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1248-58
pubmed: 17379839
Mol Cancer Ther. 2006 Mar;5(3):755-66
pubmed: 16546991
Crit Rev Oncol Hematol. 2014 Nov;92(2):133-42
pubmed: 24908570
Front Immunol. 2018 Feb 19;9:262
pubmed: 29515580
Nature. 2013 Sep 19;501(7467):328-37
pubmed: 24048065
Nat Rev Mater. 2016 Sep;1(9):
pubmed: 27668091
Adv Mater. 2017 Sep;29(34):
pubmed: 28714110
Front Oncol. 2018 Sep 25;8:390
pubmed: 30319963
Cancer Gene Ther. 2014 Nov;21(11):472-482
pubmed: 25323693
Expert Opin Biol Ther. 2016 Sep;16(9):1079-92
pubmed: 27270211
Semin Cancer Biol. 2020 May;62:166-181
pubmed: 31415910
Mol Cancer Ther. 2014 Apr;13(4):962-75
pubmed: 24502925
Cytotherapy. 2011 Sep;13(8):944-55
pubmed: 21846298

Auteurs

Youssef Slama (Y)

Unité de Recherche Études Pharmaco-Immunologiques (EPI), Université de La Réunion, CHU de La Réunion, Allée des Topazes, 97400 Saint-Denis, La Réunion, France.
Service de Radiothérapie, Clinique Sainte-Clotilde, Groupe Clinifutur, 127 Route de Bois de Nèfles, 97400 Saint-Denis, La Réunion, France.
Laboratoire Interdisciplinaire de Recherche en Santé (LIRS), RunResearch, Clinique Sainte-Clotilde, 127 Route de Bois de Nèfles, 97400 Saint-Denis, La Réunion, France.

Franck Ah-Pine (F)

Unité de Recherche Études Pharmaco-Immunologiques (EPI), Université de La Réunion, CHU de La Réunion, Allée des Topazes, 97400 Saint-Denis, La Réunion, France.
Service d'Anatomie et Cytologie Pathologiques, CHU de La Réunion sites SUD-Saint-Pierre, Avenue François Mitterrand, 97448 Saint-Pierre Cedex, La Réunion, France.

Mohamed Khettab (M)

Unité de Recherche Études Pharmaco-Immunologiques (EPI), Université de La Réunion, CHU de La Réunion, Allée des Topazes, 97400 Saint-Denis, La Réunion, France.
Service d'Oncologie Médicale, CHU de La Réunion sites SUD-Saint-Pierre, Avenue François Mitterrand, 97448 Saint-Pierre Cedex, La Réunion, France.

Angelique Arcambal (A)

Laboratoire Interdisciplinaire de Recherche en Santé (LIRS), RunResearch, Clinique Sainte-Clotilde, 127 Route de Bois de Nèfles, 97400 Saint-Denis, La Réunion, France.

Mickael Begue (M)

Service de Radiothérapie, Clinique Sainte-Clotilde, Groupe Clinifutur, 127 Route de Bois de Nèfles, 97400 Saint-Denis, La Réunion, France.
Laboratoire Interdisciplinaire de Recherche en Santé (LIRS), RunResearch, Clinique Sainte-Clotilde, 127 Route de Bois de Nèfles, 97400 Saint-Denis, La Réunion, France.

Fabien Dutheil (F)

Service de Radiothérapie, Clinique Sainte-Clotilde, Groupe Clinifutur, 127 Route de Bois de Nèfles, 97400 Saint-Denis, La Réunion, France.
Laboratoire Interdisciplinaire de Recherche en Santé (LIRS), RunResearch, Clinique Sainte-Clotilde, 127 Route de Bois de Nèfles, 97400 Saint-Denis, La Réunion, France.

Philippe Gasque (P)

Unité de Recherche Études Pharmaco-Immunologiques (EPI), Université de La Réunion, CHU de La Réunion, Allée des Topazes, 97400 Saint-Denis, La Réunion, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH